Biotech | August 06, 2021
Mark W. Womack is the new CEO of Stelis Biopharma
He will be stationed at the company HQ in Bengaluru, India
He will be stationed at the company HQ in Bengaluru, India
Five seats reserved for Wards of COVID warriors in central MBBS admission
It is designed to tackle mental health issues
FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone every minute with optional real-time glucose alarms
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
Complementary business models are the reason for the acquisition
It works as an adjunct to standard care based on robust clinical trials
India business is growing as per projections; whereas US business will bounce back soon.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
